BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Prat A, Casado E, Cortés J. New approaches in angiogenic targeting for colorectal cancer. World J Gastroenterol 2007; 13(44): 5857-5866 [PMID: 17990351 DOI: 10.3748/wjg.v13.i44.5857]
URL: https://www.wjgnet.com/1007-9327/full/v13/i44/5857.htm
Number Citing Articles
1
Wolfgang Lieb, Radwan Safa, Emelia J. Benjamin, Vanessa Xanthakis, Xiaoyan Yin, Lisa M. Sullivan, Martin G. Larson, Holly M. Smith, Joseph A. Vita, Gary F. Mitchell, Douglas B. Sawyer, Ramachandran S. Vasan. Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular functionEuropean Heart Journal 2009; 30(9) doi: 10.1093/eurheartj/ehp007
2
Preety Ghanghas, Shelly Jain, Chandan Rana, S.N. Sanyal. Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancerBiomedicine & Pharmacotherapy 2016; 78 doi: 10.1016/j.biopha.2016.01.024
3
D G Binion, M F Otterson, P Rafiee. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibitionGut 2008; 57(11) doi: 10.1136/gut.2008.152496
4
Arundhati Jana, Nancy L. Krett, Grace Guzman, Ahmer Khalid, Ozkan Ozden, Jonas J. Staudacher, Jessica Bauer, Seung Hyun Baik, Timothy Carroll, Cemal Yazici, Barbara Jung. NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathwayOncotarget 2017; 8(23) doi: 10.18632/oncotarget.16343
5
S. Di Franco, M. Todaro, F. Dieli, G. Stassi. Colorectal cancer defeating? Challenge accepted!Molecular Aspects of Medicine 2014; 39 doi: 10.1016/j.mam.2013.07.001
6
Laura Q. M. Chow, S. Gail Eckhardt. Principles of Anticancer Drug Development2011;  doi: 10.1007/978-1-4419-7358-0_14
7
Lili Nimri, Hossei Barak, Lutz Graeve, Betty Schwartz. Restoration of caveolin‐1 expression suppresses growth, membrane‐type‐4 metalloproteinase expression and metastasis‐associated activities in colon cancer cellsMolecular Carcinogenesis 2013; 52(11) doi: 10.1002/mc.21927
8
Gesiena E. van der Wal, Annette S. H. Gouw, Jan A. A. M. Kamps, Henk E. Moorlag, Marian L. C. Bulthuis, Grietje Molema, Koert P. de Jong. Angiogenesis in Synchronous and Metachronous Colorectal Liver MetastasesAnnals of Surgery 2012; 255(1) doi: 10.1097/SLA.0b013e318238346a
9
Qiaoyan Cai, Jiumao Lin, Lihui Wei, Ling Zhang, Lili Wang, Youzhi Zhan, Jianwei Zeng, Wei Xu, Aling Shen, Zhenfeng Hong, Jun Peng. Hedyotis diffusa Willd Inhibits Colorectal Cancer Growth in Vivo via Inhibition of STAT3 Signaling PathwayInternational Journal of Molecular Sciences 2012; 13(5) doi: 10.3390/ijms13056117
10
Xin-En Huang, Xiao-Chun Yan, Lin Wang, Zhu-Qing Ji, Li Li, Meng-Yan Liu, Ting Qian, Hui-Ling Shen, Han-Gang Gu, Yong Liu, Ming Gu, Li-Chun Deng. Thalidomide Combined with Chemotherapy in Treating Patients with Advanced Colorectal CancerAsian Pacific Journal of Cancer Prevention 2015; 16(17) doi: 10.7314/APJCP.2015.16.17.7867
11
Kei Sakamoto, Shin Maeda, Yohko Hikiba, Hayato Nakagawa, Yoku Hayakawa, Wataru Shibata, Ayako Yanai, Keiji Ogura, Masao Omata. Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor GrowthClinical Cancer Research 2009; 15(7) doi: 10.1158/1078-0432.CCR-08-1383
12
Sidhant Jain, Meenakshi Rana, Pooja Choubey, Sahil Kumar. Schistosoma japonicum Associated Colorectal Cancer and Its ManagementActa Parasitologica 2023; 68(4) doi: 10.1007/s11686-023-00707-9
13
Jenia Jenab-Wolcott, Bruce J Giantonio. Bevacizumab: current indications and future development for management of solid tumorsExpert Opinion on Biological Therapy 2009; 9(4) doi: 10.1517/14712590902817817
14
Stefan K. Burgdorf, Hans J. Nielsen, Jacob Rosenberg. Immunotherapy in colorectal cancerScandinavian Journal of Gastroenterology 2009; 44(3) doi: 10.1080/00365520802400909
15
LEI FAN, YUHUA LI, YANG SUN, ZHENGGANG YUE, JIN MENG, XUTAO ZHANG, RONG ZHANG, DIAN ZHANG, FENG ZHANG, QIBING MEI. Paris saponin VII inhibits metastasis by modulating matrix metalloproteinases in colorectal cancer cellsMolecular Medicine Reports 2015; 11(1) doi: 10.3892/mmr.2014.2728
16
Arundhati Jana, Archita Das, Nancy L. Krett, Grace Guzman, Alexandra Thomas, Georgina Mancinelli, Jessica Bauer, Masuko Ushio-Fukai, Tohru Fukai, Barbara Jung, Salvatore V. Pizzo. Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancerPLOS ONE 2020; 15(1) doi: 10.1371/journal.pone.0227916
17
E.S.M. Chu, S.C.W. Sze, H.P. Cheung, K.L. Wong, Q. Liu, T.B. Ng, Y. Tong. Differential effects of anti-metastatic mechanism of Tian-Xian liquid (TXL) and its bioactive fractions on human colorectal cancer modelsJournal of Ethnopharmacology 2011; 137(1) doi: 10.1016/j.jep.2011.05.035
18
Shiwei Guo, Xuehai Pang, Lingling Peng, Miao Zhan, Lei Fan, Yu Gong, Fanyuan Kang, Yuanwei Chen. Design, synthesis and biological evaluation of deuterated Tivozanib for improving pharmacokinetic propertiesBioorganic & Medicinal Chemistry Letters 2015; 25(11) doi: 10.1016/j.bmcl.2015.03.088
19
Parvaneh Rafiee, Daniel J. Stein, Victoria M. Nelson, Mary F. Otterson, Reza Shaker, David G. Binion. Thalidomide inhibits inflammatory and angiogenic activation of human intestinal microvascular endothelial cells (HIMEC)American Journal of Physiology-Gastrointestinal and Liver Physiology 2010; 298(2) doi: 10.1152/ajpgi.00385.2009
20
Anja C. Bürgers, Eckhard Lammert. Extraerythrocytic hemoglobin – A possible oxygen transporter in human malignant tumorsMedical Hypotheses 2011; 77(4) doi: 10.1016/j.mehy.2011.06.035
21
Sungweon Choi, Daisuke Sano, Melvina Cheung, Mei Zhao, Samar A. Jasser, Anderson J. Ryan, Li Mao, Wan-Tao Chen, Adel K. El-Naggar, Jeffrey N. Myers. Vandetanib Inhibits Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse ModelClinical Cancer Research 2008; 14(16) doi: 10.1158/1078-0432.CCR-08-0245
22
Subash C. Gupta, Sahdeo Prasad, Dhanya R. Sethumadhavan, Mangalam S. Nair, Yin-Yuan Mo, Bharat B. Aggarwal. Nimbolide, a Limonoid Triterpene, Inhibits Growth of Human Colorectal Cancer Xenografts by Suppressing the Proinflammatory MicroenvironmentClinical Cancer Research 2013; 19(16) doi: 10.1158/1078-0432.CCR-13-0080
23
Marc Chamberlain. Evolving strategies: future treatment of glioblastomaExpert Review of Neurotherapeutics 2011; 11(4) doi: 10.1586/ern.11.30
24
Kei Sakamoto, Shin Maeda. Targeting NF-κB for colorectal cancerExpert Opinion on Therapeutic Targets 2010; 14(6) doi: 10.1517/14728221003769903
25
Ling Lin, Jia Li, Ya-lan Wang, Xiao Lin. Relationship of PARG with PARP, VEGF and b-FGF in colorectal carcinomaChinese Journal of Cancer Research 2009; 21(2) doi: 10.1007/s11670-009-0135-3
26
Yan Ding, Xiaobing Huang, Taiping Liu, Yong Fu, Zhangping Tan, Hong Zheng, Taoli Zhou, Jigang Dai, Wenyue Xu. The Plasmodium Circumsporozoite Protein, a Novel NF-κB Inhibitor, Suppresses the Growth of SW480Pathology & Oncology Research 2012; 18(4) doi: 10.1007/s12253-012-9519-7
27
Shiva Ganjali, Amirhossein Sahebkar, Elahe Mahdipour, Khadijeh Jamialahmadi, Sepideh Torabi, Saeed Akhlaghi, Gordon Ferns, Seyed Mohammad Reza Parizadeh, Majid Ghayour-Mobarhan. Investigation of the Effects of Curcumin on Serum Cytokines in Obese Individuals: A Randomized Controlled TrialThe Scientific World Journal 2014; 2014 doi: 10.1155/2014/898361
28
Maria Di Bartolomeo, Filippo Pietrantonio, Antonia Martinetti, Roberto Buzzoni, Arpine Gevorgyan, Emilio Bajetta. Role of the Antiangiogenic Agent Bevacizumab in the Treatment of Elderly Patients with Metastatic Colorectal CancerDrugs & Aging 2011; 28(2) doi: 10.2165/11584710-000000000-00000
29
Yoo Mi Lee, Yong Sik Yoon, Seon Ae Roh, Dong Hyung Cho, Jin Cheon Kim. Invasiveness of and Drug Sensitivity to Various Anti-cancer Regimens in Five Colorectal Cancer Cell LinesJournal of the Korean Society of Coloproctology 2010; 26(2) doi: 10.3393/jksc.2010.26.2.98
30
Erika Martinelli, Teresa Troiani, Floriana Morgillo, Michele Orditura, Fernando De Vita, Giulio Belli, Fortunato Ciardiello. Emerging VEGF-receptor inhibitors for colorectal cancerExpert Opinion on Emerging Drugs 2013; 18(1) doi: 10.1517/14728214.2013.749856
31
Qiaoyan Cai, Jing Lin, Ling Zhang, Jiumao Lin, Lili Wang, Daxin Chen, Jun Peng. Comparative proteomics—network analysis of proteins responsible for ursolic acid–induced cytotoxicity in colorectal cancer cellsTumor Biology 2017; 39(3) doi: 10.1177/1010428317695015
32
Xiao-Hong Liu, Chen-Guang Bai, Yang Yuan, De-Jun Gong, Sheng-Dong Huang. Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancerWorld Journal of Gastroenterology 2008; 14(10): 1575-1581 doi: 10.3748/wjg.14.1575
33
Victoria L. Heath, Roy Bicknell. Anticancer strategies involving the vasculatureNature Reviews Clinical Oncology 2009; 6(7) doi: 10.1038/nrclinonc.2009.52
34
Flávia CM Lopes, Ana Rocha, Ana Pirraco, Luis O Regasini, Dulce HS Silva, Vanderlan S Bolzani, Isabel Azevedo, Iracilda Z Carlos, Raquel Soares. Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa BMC Complementary and Alternative Medicine 2009; 9(1) doi: 10.1186/1472-6882-9-15
35
Callisia N. Clarke, E. Scott Kopetz. Rectal Cancer2018;  doi: 10.1007/978-3-319-16384-0_19
36
Stéphanie Gout, Jacques Huot. Role of Cancer Microenvironment in Metastasis: Focus on Colon CancerCancer Microenvironment 2008; 1(1) doi: 10.1007/s12307-008-0007-2
37
Takanori Kanazawa, Ken Sugawara, Ko Tanaka, Shogo Horiuchi, Yuuki Takashima, Hiroaki Okada. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG–PCL nanomicellesEuropean Journal of Pharmaceutics and Biopharmaceutics 2012; 81(3) doi: 10.1016/j.ejpb.2012.04.021
38
Anthony Lopez, Kazuto Harada, Maria Vasilakopoulou, Namita Shanbhag, Jaffer A. Ajani. Targeting Angiogenesis in Colorectal CarcinomaDrugs 2019; 79(1) doi: 10.1007/s40265-018-1037-9
39
Fengjuan Zhao, Qingyu Zhang, Chunsheng Kang, Xiaowei Cui, Tao Wang, Peng Xu, Xuan Zhou, Jian Liu, Xiaomei Song. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivoMedical Oncology 2010; 27(3) doi: 10.1007/s12032-009-9285-x
40
Michael S Gordon. Antiangiogenic therapies: is VEGF-A inhibition alone enough?Expert Review of Anticancer Therapy 2011; 11(3) doi: 10.1586/era.11.5
41
Shahnawaz Rasheed, Peter J. McDonald, John M. Northover, Thomas Guenther. Angiogenesis and hypoxic factors in colorectal cancerPathology - Research and Practice 2008; 204(7) doi: 10.1016/j.prp.2008.03.005